Generalized Anxiety Disorder
GAD · Neurology · 1 drugs · 1 indications
Chronic anxiety disorder characterized by excessive, uncontrollable worry about everyday matters lasting at least 6 months.
Competitive Landscape (1 drugs)
| Drug | Company | Mechanism | Modality | Route | Stage |
|---|
| Ulotaront | 4578 | TAAR1/5-HT1A Agonist | Small molecule | ORAL | PHASE3 |
Indications (1)
GAD (Generalized Anxiety Disorder)
Upcoming Catalysts
Ulotaront - Schizophrenia - Ph3 - Relapse Prevention (DIAMOND 5)CLINICAL
4578H2 2026
Data from Supabase · Updated 2026-03-24